140 related articles for article (PubMed ID: 32669923)
21. [Functional Heart Complaints].
Wyss CA
Praxis (Bern 1994); 2023 Jan; 112(1):11-15. PubMed ID: 36597684
[TBL] [Abstract][Full Text] [Related]
22. Trepopnea as a diagnostic clue for malignant disease.
Carvalho D; Rei Pacheco A; Carvalho S; Ferreira R; Briosa Neves A
Rev Port Cardiol; 2024 Apr; 43(4):213-215. PubMed ID: 37481237
[No Abstract] [Full Text] [Related]
23. [Erratum to: Dyspnea-a year-long history of suffering].
Pulbere CD; Edlinger S; Sprinzl G
HNO; 2023 Aug; 71(8):525. PubMed ID: 37470871
[No Abstract] [Full Text] [Related]
24. Management of Dyspnea in Advanced Cancer: ASCO Guideline.
Hui D; Bohlke K; Bao T; Campbell TC; Coyne PJ; Currow DC; Gupta A; Leiser AL; Mori M; Nava S; Reinke LF; Roeland EJ; Seigel C; Walsh D; Campbell ML
J Clin Oncol; 2021 Apr; 39(12):1389-1411. PubMed ID: 33617290
[TBL] [Abstract][Full Text] [Related]
25. Management of breathlessness in patients with cancer: ESMO Clinical Practice Guidelines
Hui D; Maddocks M; Johnson MJ; Ekström M; Simon ST; Ogliari AC; Booth S; Ripamonti C;
ESMO Open; 2020 Dec; 5(6):e001038. PubMed ID: 33303485
[No Abstract] [Full Text] [Related]
26. Effect of Sustained-Release Morphine for Refractory Breathlessness in Chronic Obstructive Pulmonary Disease on Health Status: A Randomized Clinical Trial.
Verberkt CA; van den Beuken-van Everdingen MHJ; Schols JMGA; Hameleers N; Wouters EFM; Janssen DJA
JAMA Intern Med; 2020 Oct; 180(10):1306-1314. PubMed ID: 32804188
[TBL] [Abstract][Full Text] [Related]
27. Pharmacologic Interventions for Breathlessness in Patients With Advanced Cancer: A Systematic Review and Meta-analysis.
Feliciano JL; Waldfogel JM; Sharma R; Zhang A; Gupta A; Sedhom R; Day J; Bass EB; Dy SM
JAMA Netw Open; 2021 Feb; 4(2):e2037632. PubMed ID: 33630086
[TBL] [Abstract][Full Text] [Related]
28. Nonpharmacological Interventions for Managing Breathlessness in Patients With Advanced Cancer: A Systematic Review.
Gupta A; Sedhom R; Sharma R; Zhang A; Waldfogel JM; Feliciano JL; Day J; Gersten RA; Davidson PM; Bass EB; Dy SM
JAMA Oncol; 2021 Feb; 7(2):290-298. PubMed ID: 33211072
[TBL] [Abstract][Full Text] [Related]
29. Unanswered questions and future direction in the management of terminal breathlessness in patients with cancer.
Mori M; Yamaguchi T; Matsuda Y; Suzuki K; Watanabe H; Matsunuma R; Kako J; Imai K; Usui Y; Matsumoto Y; Hui D; Currow D; Morita T
ESMO Open; 2020; 5 Suppl 1(Suppl 1):e000603. PubMed ID: 33558034
[TBL] [Abstract][Full Text] [Related]
30. End-of-Life Care: Palliative Management of Symptoms at the End of Life.
Ross JS
FP Essent; 2020 Nov; 498():11-20. PubMed ID: 33166102
[TBL] [Abstract][Full Text] [Related]
31. Opioid Management of Dyspnea at End of Life: A Systematic Review.
Obarzanek L; Wu W; Tutag-Lehr V
J Palliat Med; 2023 May; 26(5):711-726. PubMed ID: 36453988
[No Abstract] [Full Text] [Related]
32. Opioids in patients with COPD and refractory dyspnea: literature review and design of a multicenter double blind study of low dosed morphine and fentanyl (MoreFoRCOPD).
van Dijk M; Mooren KJM; van den Berg JK; van Beurden-Moeskops WJC; Heller-Baan R; de Hosson SM; Lam-Wong WY; Peters L; Pool K; Kerstjens HAM
BMC Pulm Med; 2021 Sep; 21(1):289. PubMed ID: 34507574
[TBL] [Abstract][Full Text] [Related]
33. Dyspnea. Mechanisms, assessment, and management: a consensus statement. American Thoracic Society.
Am J Respir Crit Care Med; 1999 Jan; 159(1):321-40. PubMed ID: 9872857
[No Abstract] [Full Text] [Related]
34. Nurses' perceptions to alleviate dyspnoea in inpatients with advanced cancer while receiving palliative care.
Kero J; Koivisto JM; Lee SH; Haavisto E
Nurs Open; 2024 Jan; 11(1):e2038. PubMed ID: 38268248
[TBL] [Abstract][Full Text] [Related]
35. Which breathlessness dimensions associate most strongly with fatigue?-The population-based VASCOL study of elderly men.
Cristea L; Olsson M; Sandberg J; Kochovska S; Currow D; Ekström M
PLoS One; 2023; 18(12):e0296016. PubMed ID: 38117831
[TBL] [Abstract][Full Text] [Related]
36. Interventions for palliative symptom control in COVID-19 patients.
Andreas M; Piechotta V; Skoetz N; Grummich K; Becker M; Joos L; Becker G; Meissner W; Boehlke C
Cochrane Database Syst Rev; 2021 Aug; 8(8):CD015061. PubMed ID: 34425019
[TBL] [Abstract][Full Text] [Related]
37. Management of dyspnea in palliative care.
Crombeen AM; Lilly EJ
Curr Oncol; 2020 Jun; 27(3):142-145. PubMed ID: 32669923
[TBL] [Abstract][Full Text] [Related]
38. The symptomatic relief of dyspnea.
Elia G; Thomas J
Curr Oncol Rep; 2008 Jul; 10(4):319-25. PubMed ID: 18778558
[TBL] [Abstract][Full Text] [Related]
39. [Dyspnea in lung cancer].
Bonnichon A; Le Floch H; Rivière F; Staub E; Mairovitz A; Marotel C; Vaylet F; Margery J
Rev Pneumol Clin; 2008 Apr; 64(2):62-8. PubMed ID: 18589285
[TBL] [Abstract][Full Text] [Related]
40. Management of dyspnea in patients with chronic obstructive pulmonary disease.
Abernethy AP; Uronis HE; Wheeler JL; Currow DC
Wien Med Wochenschr; 2009 Dec; 159(23-24):583-90. PubMed ID: 20151347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
